SMARCB1 and amyotrophic lateral sclerosis: A subset of our organoid datasets come from studies that performed diverse perturbations (22q11.2 deletion, SMARCB1 knockdown, exposure to Alzheimer’s serum, SETBP1 point mutations, amyotrophic lateral sclerosis patient-derived organoids).